Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker SRAD
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Michael Connolly Miller Chief Legal Officer | SRAD Sportradar Group AG | Sale | 1,840 | $12.10 | $22.3K Sale | Form 4 ↗ |
| Aug 28, 2026 | James Scott Ritter Chief Accounting Officer | SRAD Sportradar Group AG | Sale | 3,500 | $12.83 | $44.9K Sale | Form 4 ↗ |
| Jun 10, 2026 | Michael Connolly Miller Chief Legal Officer | SRAD Sportradar Group AG | Sale | 1,500 | $16.50 | $24.8K Sale | Form 4 ↗ |
| May 6, 2026 | Carsten Koerl Chief Executive Officer, Director | SRAD Sportradar Group AG | Buy | 157,801 | $13.49 | $2.1M Buy | Form 4 ↗ |
| May 5, 2026 | Carsten Koerl Chief Executive Officer, Director | SRAD Sportradar Group AG | Buy | 158,000 | $13.40 | $2.1M Buy | Form 4 ↗ |
| May 4, 2026 | Carsten Koerl Chief Executive Officer, Director | SRAD Sportradar Group AG | Buy | 182,000 | $13.38 | $2.4M Buy | Form 4 ↗ |
| May 1, 2026 | Carsten Koerl Chief Executive Officer, Director | SRAD Sportradar Group AG | Buy | 143,000 | $13.23 | $1.9M Buy | Form 4 ↗ |
| Apr 30, 2026 | Carsten Koerl Chief Executive Officer, Director | SRAD Sportradar Group AG | Buy | 111,100 | $13.06 | $1.5M Buy | Form 4 ↗ |
| Apr 30, 2026 | Marc Walder Director | SRAD Sportradar Group AG | Buy | 66,000 | $12.77 | $842.8K Buy | Form 4 ↗ |
| Apr 30, 2026 | Jeffery W. Yabuki Director | SRAD Sportradar Group AG | Buy | 2,000 | $13.00 | $26.0K Buy | Form 4 ↗ |
| Apr 30, 2026 | Jeffery W. Yabuki Director | SRAD Sportradar Group AG | Buy | 5,000 | $12.88 | $64.4K Buy | Form 4 ↗ |
| Apr 30, 2026 | Jeffery W. Yabuki Director | SRAD Sportradar Group AG | Buy | 3,000 | $13.00 | $39.0K Buy | Form 4 ↗ |
| Apr 30, 2026 | Rajani Ramanathan Director | SRAD Sportradar Group AG | Buy | 8,003 | $12.50 | $100.0K Buy | Form 4 ↗ |
| Apr 30, 2026 | William Kurtz Director | SRAD Sportradar Group AG | Buy | 8,000 | $12.97 | $103.8K Buy | Form 4 ↗ |
| Apr 30, 2026 | George Fleet Director | SRAD Sportradar Group AG | Buy | 7,850 | $12.73 | $99.9K Buy | Form 4 ↗ |
| Apr 30, 2026 | Deirdre Mary Bigley Director | SRAD Sportradar Group AG | Buy | 3,940 | $12.57 | $49.5K Buy | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances